改善2型糖尿病患者社会心理照护的干预研究
本研究为集群随机对照实用性试验,采用平行收敛混合方法设计,测试INTEGRATE-D实施支持干预在初级保健诊所改善2型糖尿病患者社会心理照护的可行性与可接受性。两个干预诊所接受ADA推荐社会心理照护的定制培训与促进支持,两个对照诊所无干预。干预诊所认为INTEGRATE-D可接受、与需求契合且可行,但对过程指标和临床结局的影响结果不一。
要点
- INTEGRATE-D在初级保健诊所中可接受、与需求契合且可行。
- COVID-19压力可能削弱了干预的可行性。
- 干预对抑郁筛查、糖尿病管理及PHQ-9、A1C等结局影响不一。
核心结论
- INTEGRATE-D在初级保健诊所中可接受、与需求契合且可行,但需更大样本和面对面促进条件下进一步试点。
研究设计与样本
- 集群随机对照实用性试验,采用平行收敛混合方法设计,两个干预诊所和两个对照诊所参与。
主要发现
- 干预诊所接受培训并获15个月促进支持,因COVID-19限制改为远程交付。
- 干预诊所认为INTEGRATE-D可接受、与需求契合且可行,定性数据提示COVID-19压力削弱可行性。
- INTEGRATE-D对过程指标和临床结局指标的影响结果不一。
关键数值与推荐
- 干预诊所接受ADA推荐社会心理照护的定制培训及促进支持以识别和支持临床变革。
- 对照诊所不接受干预。
- 主要结局为干预可接受性、适宜性和可行性;次要结局包括抑郁筛查、糖尿病管理等过程指标及PHQ-9和A1C等临床结局。
临床怎么用
- 在初级保健中可尝试采用INTEGRATE-D框架改善2型糖尿病社会心理照护,但需考虑本地适配和资源支持。
局限性
- 样本量小,仅为概念验证研究。
- COVID-19相关限制导致干预改为远程交付且强度降低。
- 随机化未解决的干预诊所与对照诊所间差异可能影响结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This proof-of-concept study tested the feasibility and acceptability of INTEGRATE-D, an implementation support intervention for primary care clinics to improve the psychosocial care of patients with type 2 diabetes. METHODS: Cluster randomized controlled pragmatic trial, with a parallel, convergent mixed methods design. Two Intervention Clinics (ICs) were offered tailored training on American Diabetes Association (ADA)-recommended psychosocial care and facilitation to identify and support clinical change. Two Control Clinics (CCs) received no intervention. PRIMARY OUTCOMES: intervention acceptability, appropriateness and feasibility. SECONDARY OUTCOMES: process-of-care metrics (eg, depression screening, diabetes management) and clinical outcomes measures (PHQ-9 and A1C). Qualitative data were collected to assess implementation and experience with the intervention. RESULTS: ICs were offered training and received 15-months of facilitation. To accommodate COVID-19-related safety restrictions, the intervention was changed to be delivered virtually (eg, remote facilitation and training sessions). Despite an adapted delivery and COVID-19 and staffing stressors, clinics exposed to INTEGRATE-D found it to be acceptable, well-aligned with clinics' needs, and feasible. Qualitative data suggest COVID-19 stressors tempered feasibility. The effect of INTEGRATE-D on process and clinical outcome measures were mixed. Several factors, including differences in ICs and CCs not addressed in randomization and delivery of a less intensive intervention due to the pandemic, may help explain these results. CONCLUSIONS: Given the growing number of people with type 2 diabetes and the importance of psychosocial care for these patients, INTEGRATE-D warrants further pilot-testing with a larger sample of clinics and patients, and under conditions where in-person facilitation and expanded training is possible.
引用
- Cohen DJ, Sweeney SM, Springer R, et al. Intervention to Improve Psychosocial Care for People with Type 2 Diabetes. J Am Board Fam Med. 2025. PMID: 40578908. doi:10.3122/jabfm.2024.240265R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。